INVEGA SUSTENNA® is approved for the treatment of schizoaffective disorder

Access and Affordability for INVEGA SUSTENNA®

Access

99% of Medicare Part D plan lives are covered.

United States map of INVEGA SUSTENNA coverage

Click here for state coverage resources.

Disclaimer

Collected on February 1, 2017.

The information provided is not a guarantee of coverage or payment (partial or full). Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures. This document is presented for informational purposes only and is not intended to provide reimbursement or legal advice, nor does it promise or guarantee coverage, levels of reimbursement, payment, or charge. It is not intended to increase or maximize reimbursement by any payer. Laws, regulations, and policies concerning reimbursement are complex and are updated frequently. While we have made an effort to be current as of the issue date of this document, the information may not be as current or comprehensive when you view it. Please refer to http://www.medicare.gov, and/or the applicable plan’s website, or contact the plan for more information about coverage of any restrictions or prerequisites that may apply. We strongly recommend you consult the payer organization for its reimbursement policies. All information is subject to change.

Affordability

Medicare

Dual-Eligible Medicare/Medicaid Patient

Full-subsidy LIS patients may be eligible to pay $3.70 to $8.25 for branded drugs.2

Commercial Insurance

Janssen CarePath Savings Program helps eligible patients save on out-of-pocket medication costs for INVEGA SUSTENNA® and INVEGA TRINZA®. Commercially-insured patients who are eligible will:

  • Pay $10 per dose for out-of-pocket medication costs
  • $8,000 maximum program benefit per calendar year or 13 doses, whichever comes first, for INVEGA SUSTENNA®
  • $8,000 maximum program benefit per calendar year or 4 doses, whichever comes first, for INVEGA TRINZA®

This program is only available to individuals age 18 or older using commercial or private health insurance for their Janssen medication, including plans available through state and federal healthcare exchanges. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. There is no income requirement. Program does not cover the cost to give patients their treatment. See full eligibility requirements (underline full eligibility requirements and link to InvegaSustenna.JanssenCarePathSavings.com)

To get started, your patient must enroll at Neuro.JanssenCarePathSavings.com or call 877-524-3579, Monday-Friday, 8:00 AM to 8:00 PM ET.

 

Click here for Savings Card and to see full details and restrictions

LIS=low-income subsidy.

Program requirements apply.

References: 1. Data on file. Janssen Pharmaceuticals, Inc., Titusville, NJ. Coverage data provided by MMIT. 2. Announcement of calendar year (CY) 2017 Medicare Advantage capitation rates and Medicare Advantage and Part D payment policies and final call letter. US Centers for Medicare & Medicaid Services website. https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Announcement2017.pdf. Updated April 4, 2016. Accessed June 15, 2017. 3. Data on file. Janssen Pharmaceuticals, Inc., Titusville, NJ. Instant savings program. https://sservices.trialcard.com/Coupon/InvegaTrinza. Updated January 2018. Accessed February 7, 2019.

Content area 1.2